贝叶斯推理用于预测主要增强疫苗接种方案中的生存概率
Yuelin Lu1, Bradley P Carlin2, John W Seaman3
1Statistical Innovation, Oncology & Vaccines, GlaxoSmithKline Plc, Upper Providence, Philadelphia, USA.
Statistics in medicine
|December 18, 2023
概括
这项研究使用贝叶斯法来预测基于剂量度的埃博拉疫苗生存概率. 这些发现支持使用主要增强疫苗接种策略来有效免疫人口.
科学领域:
- 免疫学 免疫学 免疫学
- 生物统计学 生物统计学
- 流行病学 流行病学
背景情况:
- 主动推进疫苗接种策略,特别是异质方案,为人口疫苗接种提供持久的免疫力和有利的安全性.
- 估计疫苗接种后的生存概率对于疫苗开发和部署至关重要.
- 埃博拉疫苗的开发需要强大的方法来评估有效性和预测结果.
研究的目的:
- 为埃博拉疫苗开发一个贝叶斯框架,用于估计埃博拉疫苗在主要增强疫苗接种方案中的生存概率.
- 模拟疫苗剂量度,诱导的抗体水平和生存概率之间的关系.
- 为未来接种疫苗的人群提供一种基于注射剂量的生存概率预测方法.
主要方法:
- 使用了在Stan中实现的两级层次的 Bayesian 模型.
- 使用贝叶斯响应表面模型 (剂量度与抗体计数) 建模剂量反应关系.
- 使用贝叶斯生存概率模型 (抗体计数到生存) 建模了抗体-反应关系.
主要成果:
- 成功结合贝叶斯响应表面和生存模型,从剂量度预测生存概率.
- 用模拟和现实数据证明了模型的实用性.
- 通过模拟研究评估模型性能,证实其预测能力.
结论:
- 开发的等级贝叶斯模型有效地使用剂量度预测埃博拉疫苗生存概率.
- 这种方法为药物协同效应模型的新应用提供了评估主要提升疫苗疗效的新方法.
- 该框架允许就疫苗接种策略和对人口健康的剂量优化做出明智的决定.
相关概念视频
Parametric Survival Analysis: Weibull and Exponential Methods
445
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
445
Assumptions of Survival Analysis
134
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
134
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Introduction To Survival Analysis
243
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
243
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Kaplan-Meier Approach
150
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
150


